Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts

Blood, Vol. 113, Issue 11, 2568-2577, March 12, 2009
This Article
Right arrow Abstract
Right arrow Full Text
Services
Right arrow Email this article to a friend
Right arrow Alert me to new issues of the journal
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via CrossRef

De novo induction of platelet-specific CD4+CD25+ regulatory T cells from CD4+CD25 cells in patients with idiopathic thrombocytopenic purpura
Blood Zhang et al. 113: 2568

Supplemental materials for: Zhang et al

Generation of Dendritic cells
Briefly, CD14+ monocytes were separated from PBMCs of ITP patients using immunomagnetic CD14 microbeads (Miltenyi Biotech) and cultured for 5 days in complete RPMI 1640 medium supplemented with 15% fetal bovine serum, 1000U/mL rhGM-CSF and 1000U/mL rhIL-4 (R&D Systems, Minneapolis, MN). For mature DCs (mDCs), fresh medium containing rhGM-CSF and rhIL-4 plus 1000U/mL rhTNF-α (R&D Systems) was added to the cultures on day 5 and cultured for 2 additional days. For fluorescence-activated cell sorting (FACS) analysis monocytes or DCs were incubated for 20-minute at 4°C with FITC- or PE-labeled mAbs against HLA-DR, CD83 and CD86 (BD PharMingen, San Diego, CA) and analyzed on a FACScalibur (Becton Dickinson, Mountain View, CA).

Microarray analysis

RNA isolation. GP-iTreg-treated imDCs were negatively selected by depleting iTreg with CD4 magnetic beads (Miltenyi Biotech) before RNA isolation after co-culture with GPIIb/IIIa-iTreg. Total RNA was extracted from GP-iTreg-treated or untreated imDCs generated from the same patient according to the manufacturer’s instructions. RNA was further purified with an RNA clean-up kit (Macherey-Nagel, Germany) and quantified by using of spectrophotometer. RNA quality from each sample was assessed by visualization of the 28S/18S ribosomal RNA ratio on 1.2% formamide agarose gel.

Labeling and hybridizations. We employed two-channel microarray technology including 22K 70-mer oligonucleotide microarrays to interrogate the expression profiling of GP-iTreg-treated or untreated imDCs according to a previous published protocol of CapitalBio Corporation (Beijing, China).1 The experiments were reproduced for 5 independent patients.

Microarray data analysis. Raw data was extracted from the TIFF images using LuxScan 3.0 software (CapitalBio). A spot-exclusion method was adopted to filter faint spots in which genes whose signal intensities were in the lowest 50% were excluded from further analysis.1 Then an intensity-dependent LOWESS program in the R language package was used to normalize the two channel ratio values. As a measure of technical replication, each experiment also had a corresponding dye swap.

We used Gene Cluster 3.0 and Eisen’s Treeview software (Stanford University, Palo Alto, CA) to compare similarities among individual samples. Cy3/Cy5 ratios were log-transformed (base 2), median centered by arrays and genes, and hierarchically clustered (average linkage correlation metric). To determine gene products with a significant increase of expression, we interrogated our data sets for an increase in average intensity of at least 2 fold after 24-hour of co-culture. Statistical comparisons were done by using the one class method in significance analysis of microarray (SAM) software 3.0 (Stanford University). In order to identify the functional classes of selected genes and the biochemical pathways involved in induction of tolerance, the selected genes were submitted to BIOCARTA database freely available at http://www.biorag.org.

Quantitative RT-PCR
Total RNA obtained from DCs as described in “Microarray analysis” was used to generate cDNA with oligo (dT) primers using SuperScript II RNase H-Reverse Transcriptase Kit (Invitrogen). Quantitative RT-PCR was performed in a Light Cycler (Roche Diagnostics, Mannheim, Germany) using a SYBR Green I PCR kit (Roche) in triplicates. The average threshold cycles (Ct) of the duplicates were used to calculate the fold changes between GP-iTreg-modulated or unmodulated imDCs. The amplification reactions were performed with 10 µM of each primer. The resulting data were analyzed with the comparative Ct method for relative gene expression quantification. Specificity of the expected products was demonstrated by melting curves analysis. Glyceraldehyde-3-phosphate dehydrogenase was used as an internal control to normalize for the abundance of mRNA in each sample.

REFERENCE

1. Patterson TA, Lobenhofer EK, Fulmer-Smentek SB, et al. Performance comparison of one-color and two-color platforms within the MicroArray Quality Control (MAQC) project. Nat Biotechnol. 2006; 24:1140-1150.

Files in this Data Supplement:

  • Table S1. Clinical characteristics of study subjects (PDF, 10.5 KB)

  • Table S2. Oligonucleotides used for quantitative RT-PCR (PDF, 14.1 KB)

  • Table S3. Genes differentially expressed in DCs from patients with ITP after exposure to GP-specific iTreg cells (PDF, 129 KB)

  • Figure S1. Induced Treg displayed stable Foxp3 expression and suppressive function (JPG, 71.7 KB) -
    The isolated CD4+CD25CD45RA+ T cells were stimulated with mDCs pre-pulsed with trypsin-digested GPIIb/IIIa in complete medium supplemented with IL-2 (20U/mL) in the presence (iTreg) or absence (non-TGF-β-treated T cells) of TGF-β1 (5ng/mL). Seven days later the CD4+CD25+ cells were purified and rested in IL-2 (20U/mL) for additional 1-week and analyzed on day 14 for Foxp3 expression (A), anergic state (B) or suppressive activity (C). (A) Foxp3 expression by GPIIb/IIIa-specific iTreg. Results were representative of 8 independent experiments. (B) For analysis of anergic state, the rested iTreg (2 × 105) or non-TGF-β-treated T cells (2 × 105) were restimulated with irradiated GPIIb/IIIa-loaded DC at a 10:1 ratio for 3 days. During the last 16 hours of incubation, the cells were pulsed with 1µCi 3H thymidine/well. The 3H thymidine incorporation was determined with a β-scintillation reader and shown as mean ± SD cpm (n = 8). (C) For analysis of suppressive activity, the rested iTreg (2 × 105) or non-TGF-β-treated T cells (2 × 105) were cultured with GPIIb/IIIa-loaded DC (2 × 104) in the presence of CFSE-labeled GPIIb/IIIa-reactive T cells (2 × 105). CFSE-labeled GPIIb/IIIa-reactive T cells that were cultured with autologous DCs loaded with the respective antigen were used as control. After 3 days of culture proliferation was measured as the percentage of proliferating GP-reactive T cells and shown as mean ± SD (n = 8) with error bars representing standard deviation. (D) In two randomly selected patients, after 7-day stimulation the iTreg were rested in IL-2 (20U/mL) for additional 3-week. The rested cells were tested for Foxp3 expression and suppressive activity on day 28 as described above.





This Article
Right arrow Abstract
Right arrow Full Text
Services
Right arrow Email this article to a friend
Right arrow Alert me to new issues of the journal
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via CrossRef

 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 2009 by American Society of Hematology         Online ISSN: 1528-0020